ABEONA THERAPEUTICS INC.

ABEO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Assets
Cash & Equivalents $137.8M $69.1M $40.1M $11.5M $424.0K $396.0K $2.5M $7.0M
Accounts Receivable $107.0K $124.0K $115.0K $35.0K $74.0K $840.0K $333.0K $1.0M
Inventory $0 $194.0K $151.0K $0
Total Current Assets $140.6M $69.4M $40.6M $11.6M $575.0K $1.7M $3.3M $8.1M
Property, Plant & Equipment $1.4M $721.0K $350.0K $4.0K $6.0K $7.0K $51.0K $32.0K
Goodwill $32.5M $32.5M $32.5M $0
Intangible Assets (Excl. Goodwill) $4.0M $8.4M $6.6M $5.0M $0 $0 $362.0K $574.0K
Total Assets $178.8M $111.1M $80.1M $16.6M $613.0K $1.7M $3.8M $8.8M
Liabilities
Accounts Payable $1.9M $3.7M $875.0K $1.9M $863.0K $2.0M $1.7M $3.0M
Total Current Liabilities $5.6M $8.3M $1.5M $2.9M $9.0M $6.6M $12.2M $14.3M
Long-Term Debt
Total Liabilities $8.7M $12.0M $12.3M $11.8M $15.4M $18.8M $21.4M $29.6M
Stockholders' Equity
Retained Earnings $-359.8M $-332.5M $-310.6M $-296.1M $-266.4M $-268.0M $-255.4M $-251.1M
Total Stockholders' Equity $170.1M $99.1M $67.7M $4.8M $-14.8M $-17.1M $-17.6M $-20.8M
← Newer Page 2 of 3 Older →